Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Kidney Int. 2017 Dec 19;93(4):842–854. doi: 10.1016/j.kint.2017.09.029

Figure 6. Systemic administration of ELP-VEGF did not result in significant changes in off-target expression of angiogenic factors.

Figure 6

Comparative protein expression and quantification (2 representative bands per group) of vascular endothelial growth factor (VEGF), its receptor Flk-1, HGF-receptor cMet, total and phosphorylated (p)-akt, ERK ½, and endothelial nitric oxide synthase (eNOS) in the contralateral kidney, liver, spleen, and heart of untreated and ELP-VEGF IV treated pigs. #p=0.06 vs. RVD.